A year after embarking on a new HQ and manufacturing site, AbCellera starts second phase of its buildout

A year ago, Canadian antibody biotech AbCellera broke ground on the first phase of its headquarters expansion in Vancouver, along with a new manufacturing site in the city. Now, the company is forging ahead with the second part of the project.

The company has broken ground on the next phase building out what will ultimately be a 380,000-square-foot campus. AbCellera hopes to include lab and office space to support its work in antibody development.